
Sign up to save your podcasts
Or


In this episode, we discuss a comprehensive study on the potential cardiovascular risks of ADHD medication. Although these medications pose minimal risk for those without preexisting conditions, there seems to be an elevated risk for those with preexisting cardiovascular diseases. Should we confidently prescribe these medications?
Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.
By Psychopharmacology Institute4.6
268268 ratings
In this episode, we discuss a comprehensive study on the potential cardiovascular risks of ADHD medication. Although these medications pose minimal risk for those without preexisting conditions, there seems to be an elevated risk for those with preexisting cardiovascular diseases. Should we confidently prescribe these medications?
Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

75 Listeners

149 Listeners

262 Listeners

3,340 Listeners

158 Listeners

565 Listeners

1,347 Listeners

715 Listeners

240 Listeners

566 Listeners

17 Listeners

471 Listeners

725 Listeners

185 Listeners

140 Listeners